Kissei
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Kissei
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.
has abstract
Kissei Pharmaceutical is a pha ...... sian countries, but not China.
@en
founding date
1946-08-09
founding year
key person
location city
number of employees
Link from a Wikipage to an external page
Wikipage page ID
62,730,357
page length (characters) of wiki page
Wikipage revision ID
1,011,163,646
Link from a Wikipage to another Wikipage
founded
1946-08-09
hq location city
hq location country
Japan
@en
industry
Pharmaceutical products, therapeutic and care foods
@en
ISIN
JP3240600001
@en
key people
Mutsuo Kanzawa
@en
name
Kissei Pharmaceutical
@en
num employees
website
wikiPageUsesTemplate
comment
Kissei Pharmaceutical is a pha ...... sian countries, but not China.
@en
label
Kissei
@en
sameAs
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Kissei Pharmaceutical
@en